Transcriptome analysis of ankylosing spondylitis patients before and after TNF-α inhibitor therapy reveals the pathways affected
Genes & Immunity · 2017-09 · 18 (3) · 184-190
DOI: 10.1038/gene.2017.19 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes & Immunity, online erschienen am 24.08.2017. Verfasst von X B Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Department, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Transcriptome. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Tumor necrosis factor-α (TNF-α) inhibitors are highly effective in suppressing inflammation in ankylosing spondylitis (AS) patients, and operate by suppression of TFN-α and downstream immunological pathways. To determine the mechanisms of action of TNF-α inhibitors in AS patients, we used transcriptomic and bioinformatic approaches on peripheral blood mononuclear cells from AS patients pre and post treatment. We found 656 differentially expressed genes, including the genome-wide significant AS-associated genes, IL6R, NOTCH1, IL10, CXCR2 and TNFRSF1A. A distinctive gene expression profile was found between male and female patients, mainly because of sex chromosome-linked genes and interleukin 17 receptor C, potentially accounting for the differences in clinical manifestation and treatment response between the genders. In addition to immune and inflammation regulatory pathways, like intestinal immune network for IgA production, cytokine-cytokine receptor interaction, Ras signaling pathway, allograft rejection and hematopoietic cell lineage, KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway analyses revealed that infection-associated pathways (influenza A and toxoplasmosis) and metabolism-associated pathways were involved in response to TNF-α inhibitor treatment, providing insight into the mechanism of TNF-α inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Rheumatology Department, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
- Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology (QUT) at Translational Research Institute, Brisbane, Australia.
- Cancer and Molecular Medicine Program, School of Biomedical Sciences, Institute of Health and Biomedical Innovation, Queensland University of Technology (QUT), Brisbane, Queensland, Australia.
- Australian Prostate Cancer Research Centre-Queensland, Translational Research Institute, Woolloongabba, Queensland, Australia.
- Centre for Precision Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Zitieren
APA
Wang, X. B., Ellis, J. J., Pennisi, D. J., Song, X., Batra, J., Hollis, K., Bradbury, L. A., Li, Z., Kenna, T. J., & Brown, M. A. (2017). Transcriptome analysis of ankylosing spondylitis patients before and after TNF-α inhibitor therapy reveals the pathways affected. Genes & Immunity, 18(3), 184-190. https://doi.org/10.1038/gene.2017.19
Vancouver
Wang XB, Ellis JJ, Pennisi DJ, Song X, Batra J, Hollis K, et al. Transcriptome analysis of ankylosing spondylitis patients before and after TNF-α inhibitor therapy reveals the pathways affected. Genes & Immunity. 2017;18(3):184-190. doi:10.1038/gene.2017.19
BibTeX
@article{Wang2017,
author = {Wang, X B and Ellis, J J and Pennisi, D J and Song, X and Batra, J and Hollis, K and Bradbury, L A and Li, Z and Kenna, T J and Brown, M A},
title = {Transcriptome analysis of ankylosing spondylitis patients before and after TNF-α inhibitor therapy reveals the pathways affected},
journal = {Genes & Immunity},
year = {2017},
volume = {18},
number = {3},
pages = {184--190},
doi = {10.1038/gene.2017.19}
}
EUVIMED